Friday, April 1st, 2016 - WiseGuyReports adds“Duchenne Muscular Dystrophy Therapeutics & Drugs Pipeline Review, H1 2016”reports to its database. We can offer you discount on this report.

Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2016’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Duchenne Muscular Dystrophy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Duchenne Muscular Dystrophy and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.


For more information or any query mail at [email protected]

Duchenne Muscular Dystrophy - Companies Involved in Therapeutics Development

  • Acceleron Pharma, Inc.
    Anagenesis Biotechnology
    Asklepios BioPharmaceutical, Inc.
    Bamboo Therapeutics, Inc.
    BioMarin Pharmaceutical Inc.
    Bristol-Myers Squibb Company
    Capricor Therapeutics, Inc.
    Catabasis Pharmaceuticals, Inc.
    Daiichi Sankyo Company, Limited
    Debiopharm International S.A.
    Editas Medicine, Inc.
    Eli Lilly and Company
    EryDel SPA
    FibroGen, Inc.
    Galapagos NV
    GTx, Inc.
    Idera Pharmaceuticals, Inc.
    Italfarmaco S.p.A.
    La Jolla Pharmaceutical Company
    Marathon Pharmaceuticals, LLC
    Marina Biotech, Inc.
    Merck KGaA
    Milo Biotechnology LLC
    MyoTherix Inc.
    NicOx S.A.
    Nippon Shinyaku Co., Ltd.
    nLife Therapeutics, S.L.
    Nobelpharma Co., Ltd.
    Pfizer Inc.
    Prothelia, Inc.
    PTC Therapeutics, Inc.
    RASRx, LLC
    ReveraGen BioPharma, Inc.
    Santhera Pharmaceuticals Holding AG
    Sarepta Therapeutics, Inc.
    Summit Therapeutics Plc
    Taiho Pharmaceutical Co., Ltd.
    WAVE Life Sciences Ltd.
    Zambon Company S.p.A.


For more information or any query mail at [email protected]

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


- The report provides a snapshot of the global therapeutic landscape of Duchenne Muscular Dystrophy 
- The report reviews pipeline therapeutics for Duchenne Muscular Dystrophy by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved Duchenne Muscular Dystrophy therapeutics and enlists all their major and minor projects 
- The report assesses Duchenne Muscular Dystrophy therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report summarizes all the dormant and discontinued pipeline projects 
- The report reviews latest news related to pipeline therapeutics for Duchenne Muscular Dystrophy

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Duchenne Muscular Dystrophy 
- Identify potential new clients or partners in the target demographic 
- Develop strategic initiatives by understanding the focus areas of leading companies 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics 
- Devise corrective measures for pipeline projects by understanding Duchenne Muscular Dystrophy pipeline depth and focus of Indication therapeutics 
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope 
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


For more information or any query mail at [email protected]


Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Duchenne Muscular Dystrophy, Duchenne Muscular Dystrophy Industry, Duchenne Muscular Dystrophy Market, Duchenne Muscular Dystrophy Market Trend, Duchenne Muscular Dystrophy Industry Trends, Duchenne Muscular Dystrophy Market Share, Duchenne Muscular Dystr




More Formats